Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).

Donovan JL, Peters TJ, Noble S, Powell P, Gillatt D, Oliver SE, Lane JA, Neal DE, Hamdy FC; ProtecT Study Group.

J Clin Epidemiol. 2003 Jul;56(7):605-9.

PMID:
12921927
2.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
3.

A systematic review of randomized trials in localized prostate cancer.

Alibhai SM, Klotz LH.

Can J Urol. 2004 Feb;11(1):2110-7. Review.

PMID:
15003149
4.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

5.

Racial differences in prostate cancer treatment outcomes: a systematic review.

Peters N, Armstrong K.

Cancer Nurs. 2005 Mar-Apr;28(2):108-18. Review.

PMID:
15815180
6.

Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia.

Fowler C, McAllister W, Plail R, Karim O, Yang Q.

Health Technol Assess. 2005 Feb;9(4):iii-iv, 1-30. Review.

7.

Cost-effectiveness of health research study participant recruitment strategies: a systematic review.

Huynh L, Johns B, Liu SH, Vedula SS, Li T, Puhan MA.

Clin Trials. 2014 Oct;11(5):576-83. doi: 10.1177/1740774514540371. Epub 2014 Jun 30. Review.

9.

Comparative effectiveness research in localized prostate cancer treatment.

Hoffman RM, Penson DF, Zietman AL, Barry MJ.

J Comp Eff Res. 2013 Nov;2(6):583-93. doi: 10.2217/cer.13.66. Review.

PMID:
24236797
10.

Difficulties in recruiting older people in clinical trials: an examination of barriers and solutions.

Ridda I, MacIntyre CR, Lindley RI, Tan TC.

Vaccine. 2010 Jan 22;28(4):901-6. doi: 10.1016/j.vaccine.2009.10.081. Epub 2009 Nov 25. Review.

PMID:
19944149
11.

A guide to successfully recruiting patients for cardiovascular clinical trials.

DeSantis P, Gross LS, DeLuca S.

Prog Cardiovasc Nurs. 1997 Summer;12(3):24-31. Review.

PMID:
9287364
12.

A guide to undertaking economic evaluations within randomized controlled trials of treatments for lower urinary tract symptoms.

Baxter K, Coast J, Donovan J.

BJU Int. 2000 Mar;85 Suppl 1:36-41. Review. No abstract available.

13.

Patient information and consent in trials for the treatment of benign prostatic obstruction.

Thorpe AC, Neal DE.

BJU Int. 2000 Mar;85 Suppl 1:42-5. Review. No abstract available.

14.

Limitations of the randomized trial for the early detection of cancer: a clinical perspective.

Smart CR.

Cancer. 1997 May 1;79(9):1740-6. Review. No abstract available.

PMID:
9128991
15.

Management of localized prostate cancer: an epidemiological perspective.

Harwood RH.

Clin Oncol (R Coll Radiol). 1995;7(3):151-9. Review.

PMID:
7547516
16.

A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia.

Kennedy AD, Sculpher MJ, Coulter A, Dwyer N, Rees M, Horsley S, Cowley D, Kidson C, Kirwin C, Naish C, Bidgood K, Cullimore J, Kerr-Wilson R, Abrams KR, Stirrat G.

Health Technol Assess. 2003;7(8):1-76. Review. No abstract available.

17.

[Informed consent of prostate cancer management].

Sato M, Akimoto M.

Nihon Rinsho. 2000 Jul;58 Suppl:400-5. Review. Japanese. No abstract available.

PMID:
11022757

Supplemental Content

Support Center